Zoetis Inc. $ZTS Shares Sold by Fifth Third Bancorp

Key Points

• Fifth Third Bancorp trimmed its Zoetis stake by 54.8% in Q4, selling 88,783 shares and leaving 73,357 shares worth about $9.23 million; institutional ownership remains high at ~92.8%.
• Analysts are mixed with a consensus "Hold" (7 Buy / 7 Hold / 1 Sell) and an average price target of $151.75, while ZTS traded around $114 and is well below its 52‑week high of $172.23.
• Financials: Zoetis beat Q results ($1.48 EPS vs $1.40 est.) on $2.39B revenue (+3% YoY), set FY2026 EPS guidance of 7.00–7.10, and announced a $0.53 quarterly dividend (annualized $2.12, 1.9% yield).

Fifth Third Bancorp trimmed its position in Zoetis Inc. (NYSE:ZTS - Free Report) by 54.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 73,357 shares of the company's stock after selling 88,783 shares during the quarter. Fifth Third Bancorp's holdings in Zoetis were worth $9,230,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in ZTS. Global Wealth Strategies & Associates acquired a new position in shares of Zoetis in the 4th quarter worth approximately $25,000. Lodestone Wealth Management LLC acquired a new position in shares of Zoetis in the 4th quarter worth approximately $30,000. KERR FINANCIAL PLANNING Corp acquired a new position in shares of Zoetis in the 3rd quarter worth approximately $31,000. Holos Integrated Wealth LLC acquired a new position in shares of Zoetis in the 4th quarter worth approximately $32,000. Finally, Board of the Pension Protection Fund acquired a new position in shares of Zoetis in the 4th quarter worth approximately $38,000. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Wall Street Zen lowered shares of Zoetis from a "buy" rating to a "hold" rating in a report on Saturday. Citigroup assumed coverage on shares of Zoetis in a report on Wednesday, April 15th. They issued a "buy" rating and a $145.00 price objective on the stock. Piper Sandler restated a "neutral" rating and issued a $135.00 price objective (down from $190.00) on shares of Zoetis in a report on Thursday, January 22nd. BTIG Research restated a "buy" rating and issued a $160.00 price objective on shares of Zoetis in a report on Thursday, February 26th. Finally, Bank of America upped their price objective on shares of Zoetis from $135.00 to $140.00 and gave the stock a "neutral" rating in a report on Friday, February 13th. Seven equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $151.75.

Zoetis Price Performance

Shares of ZTS opened at $114.22 on Friday. Zoetis Inc. has a fifty-two week low of $112.97 and a fifty-two week high of $172.23. The firm's 50 day moving average price is $119.93 and its 200 day moving average price is $124.67. The company has a market cap of $48.05 billion, a P/E ratio of 18.97, a PEG ratio of 1.76 and a beta of 0.87. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71.

Zoetis (NYSE:ZTS - Get Free Report) last announced its earnings results on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.08. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The firm had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.36 billion. During the same period in the prior year, the firm earned $1.40 EPS. The firm's revenue for the quarter was up 3.0% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, research analysts forecast that Zoetis Inc. will post 7.01 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis's dividend payout ratio is presently 35.22%.

Zoetis Profile

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.